mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma

Efficient vaccination can be achieved by injections of in vitro transcribed mRNA (ivt mRNA) coding for antigens. This vaccine format is particularly versatile and allows the production of individualised vaccines conferring, T-cell immunity against specific cancer mutations. The CDR3 hypervariable re...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Marina Tusup, Severin Läuchli, Natalia Teresa Jarzebska, Lars E. French, Yun-Tsan Chang, Maya Vonow-Eisenring, Andreas Su, Thomas M. Kündig, Emmanuella Guenova, Steve Pascolo
Format:	Artigo
Sprog:	Inglês
Udgivet:	MDPI AG 2021-07-01
Serier:	Pharmaceutics
Fag:	in vitro transcribed mRNA ivt mRNA vaccine T-cell lymphoma CTCL TCR
Online adgang:	https://www.mdpi.com/1999-4923/13/7/1040
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!